aluates Reports

$ 0.0

Automative

Global AI-driven Drug Discovery Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-35X12900

Global AI driven Drug Discovery Market Research Report 2023

BUY CHAPTERS

Global AI-driven Drug Discovery Market Research Report 2025

Code: QYRE-Auto-35X12900

Report

April 2025

Pages:91

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Selvita S.A

Exscientia Ltd

Euretos

Iktos

Eli Lilly

Ardigen

InSilico Medicine

XtalPi

DP Technology

Entos

Benevolent

Illumina with AstraZeneca

Novo Nordisk with Microsoft

Aqemia

Zephyr AI

Cyclicarx

Terray Therapeutics

ReviveMed

MindRank

AI-driven Drug Discovery Market Size

The global market for AI-driven Drug Discovery was valued at US$ 825 million in the year 2024 and is projected to reach a revised size of US$ 1644 million by 2031, growing at a CAGR of 10.5% during the forecast period.

AI-driven Drug Discovery Market

AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for AI-driven Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-driven Drug Discovery.

The AI-driven Drug Discovery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI-driven Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the AI-driven Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of AI-driven Drug Discovery Market Report

Report Metric	Details
Report Name	AI-driven Drug Discovery Market
Accounted market size in year	US$ 825 million
Forecasted market size in 2031	US$ 1644 million
CAGR	10.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Small Molecule Drug Biological Modeling Structural Biology Others
Segment by Application	Pharmaceutical and Biotechnology Companies Research Laboratories
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Entos, Selvita, Benevolent, Exscientia, Euretos, Illumina with AstraZeneca, Novo Nordisk with Microsoft, Iktos, Aqemia, Zephyr AI, Cyclicarx, Eli Lilly, Terray Therapeutics, Ardigen, ReviveMed, Insilico Medicine, XtalPi, MindRank, DP Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI-driven Drug Discovery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is AI-driven Drug Discovery Market growing?

Ans: The AI-driven Drug Discovery Market witnessing a CAGR of 10.5% during the forecast period 2025-2031.

What is the AI-driven Drug Discovery Market size in 2031?

Ans: The AI-driven Drug Discovery Market size in 2031 will be US$ 1644 million.

Who are the main players in the AI-driven Drug Discovery Market report?

Ans: The main players in the AI-driven Drug Discovery Market are Entos, Selvita, Benevolent, Exscientia, Euretos, Illumina with AstraZeneca, Novo Nordisk with Microsoft, Iktos, Aqemia, Zephyr AI, Cyclicarx, Eli Lilly, Terray Therapeutics, Ardigen, ReviveMed, Insilico Medicine, XtalPi, MindRank, DP Technology

What are the Application segmentation covered in the AI-driven Drug Discovery Market report?

Ans: The Applications covered in the AI-driven Drug Discovery Market report are Pharmaceutical and Biotechnology Companies, Research Laboratories

What are the Type segmentation covered in the AI-driven Drug Discovery Market report?

Ans: The Types covered in the AI-driven Drug Discovery Market report are Small Molecule Drug, Biological Modeling, Structural Biology, Others

Recommended Reports

AI Drug Discovery

Drug Discovery R&D

AI Healthcare Diagnosis

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI-driven Drug Discovery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Small Molecule Drug

1.2.3 Biological Modeling

1.2.4 Structural Biology

1.2.5 Others

1.3 Market by Application

1.3.1 Global AI-driven Drug Discovery Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical and Biotechnology Companies

1.3.3 Research Laboratories

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global AI-driven Drug Discovery Market Perspective (2020-2031)

2.2 Global AI-driven Drug Discovery Growth Trends by Region

2.2.1 Global AI-driven Drug Discovery Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 AI-driven Drug Discovery Historic Market Size by Region (2020-2025)

2.2.3 AI-driven Drug Discovery Forecasted Market Size by Region (2026-2031)

2.3 AI-driven Drug Discovery Market Dynamics

2.3.1 AI-driven Drug Discovery Industry Trends

2.3.2 AI-driven Drug Discovery Market Drivers

2.3.3 AI-driven Drug Discovery Market Challenges

2.3.4 AI-driven Drug Discovery Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top AI-driven Drug Discovery Players by Revenue

3.1.1 Global Top AI-driven Drug Discovery Players by Revenue (2020-2025)

3.1.2 Global AI-driven Drug Discovery Revenue Market Share by Players (2020-2025)

3.2 Global AI-driven Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by AI-driven Drug Discovery Revenue

3.4 Global AI-driven Drug Discovery Market Concentration Ratio

3.4.1 Global AI-driven Drug Discovery Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI-driven Drug Discovery Revenue in 2024

3.5 Global Key Players of AI-driven Drug Discovery Head office and Area Served

3.6 Global Key Players of AI-driven Drug Discovery, Product and Application

3.7 Global Key Players of AI-driven Drug Discovery, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 AI-driven Drug Discovery Breakdown Data by Type

4.1 Global AI-driven Drug Discovery Historic Market Size by Type (2020-2025)

4.2 Global AI-driven Drug Discovery Forecasted Market Size by Type (2026-2031)

5 AI-driven Drug Discovery Breakdown Data by Application

5.1 Global AI-driven Drug Discovery Historic Market Size by Application (2020-2025)

5.2 Global AI-driven Drug Discovery Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America AI-driven Drug Discovery Market Size (2020-2031)

6.2 North America AI-driven Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America AI-driven Drug Discovery Market Size by Country (2020-2025)

6.4 North America AI-driven Drug Discovery Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe AI-driven Drug Discovery Market Size (2020-2031)

7.2 Europe AI-driven Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe AI-driven Drug Discovery Market Size by Country (2020-2025)

7.4 Europe AI-driven Drug Discovery Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific AI-driven Drug Discovery Market Size (2020-2031)

8.2 Asia-Pacific AI-driven Drug Discovery Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific AI-driven Drug Discovery Market Size by Region (2020-2025)

8.4 Asia-Pacific AI-driven Drug Discovery Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America AI-driven Drug Discovery Market Size (2020-2031)

9.2 Latin America AI-driven Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America AI-driven Drug Discovery Market Size by Country (2020-2025)

9.4 Latin America AI-driven Drug Discovery Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa AI-driven Drug Discovery Market Size (2020-2031)

10.2 Middle East & Africa AI-driven Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa AI-driven Drug Discovery Market Size by Country (2020-2025)

10.4 Middle East & Africa AI-driven Drug Discovery Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Entos

11.1.1 Entos Company Details

11.1.2 Entos Business Overview

11.1.3 Entos AI-driven Drug Discovery Introduction

11.1.4 Entos Revenue in AI-driven Drug Discovery Business (2020-2025)

11.1.5 Entos Recent Development

11.2 Selvita

11.2.1 Selvita Company Details

11.2.2 Selvita Business Overview

11.2.3 Selvita AI-driven Drug Discovery Introduction

11.2.4 Selvita Revenue in AI-driven Drug Discovery Business (2020-2025)

11.2.5 Selvita Recent Development

11.3 Benevolent

11.3.1 Benevolent Company Details

11.3.2 Benevolent Business Overview

11.3.3 Benevolent AI-driven Drug Discovery Introduction

11.3.4 Benevolent Revenue in AI-driven Drug Discovery Business (2020-2025)

11.3.5 Benevolent Recent Development

11.4 Exscientia

11.4.1 Exscientia Company Details

11.4.2 Exscientia Business Overview

11.4.3 Exscientia AI-driven Drug Discovery Introduction

11.4.4 Exscientia Revenue in AI-driven Drug Discovery Business (2020-2025)

11.4.5 Exscientia Recent Development

11.5 Euretos

11.5.1 Euretos Company Details

11.5.2 Euretos Business Overview

11.5.3 Euretos AI-driven Drug Discovery Introduction

11.5.4 Euretos Revenue in AI-driven Drug Discovery Business (2020-2025)

11.5.5 Euretos Recent Development

11.6 Illumina with AstraZeneca

11.6.1 Illumina with AstraZeneca Company Details

11.6.2 Illumina with AstraZeneca Business Overview

11.6.3 Illumina with AstraZeneca AI-driven Drug Discovery Introduction

11.6.4 Illumina with AstraZeneca Revenue in AI-driven Drug Discovery Business (2020-2025)

11.6.5 Illumina with AstraZeneca Recent Development

11.7 Novo Nordisk with Microsoft

11.7.1 Novo Nordisk with Microsoft Company Details

11.7.2 Novo Nordisk with Microsoft Business Overview

11.7.3 Novo Nordisk with Microsoft AI-driven Drug Discovery Introduction

11.7.4 Novo Nordisk with Microsoft Revenue in AI-driven Drug Discovery Business (2020-2025)

11.7.5 Novo Nordisk with Microsoft Recent Development

11.8 Iktos

11.8.1 Iktos Company Details

11.8.2 Iktos Business Overview

11.8.3 Iktos AI-driven Drug Discovery Introduction

11.8.4 Iktos Revenue in AI-driven Drug Discovery Business (2020-2025)

11.8.5 Iktos Recent Development

11.9 Aqemia

11.9.1 Aqemia Company Details

11.9.2 Aqemia Business Overview

11.9.3 Aqemia AI-driven Drug Discovery Introduction

11.9.4 Aqemia Revenue in AI-driven Drug Discovery Business (2020-2025)

11.9.5 Aqemia Recent Development

11.10 Zephyr AI

11.10.1 Zephyr AI Company Details

11.10.2 Zephyr AI Business Overview

11.10.3 Zephyr AI AI-driven Drug Discovery Introduction

11.10.4 Zephyr AI Revenue in AI-driven Drug Discovery Business (2020-2025)

11.10.5 Zephyr AI Recent Development

11.11 Cyclicarx

11.11.1 Cyclicarx Company Details

11.11.2 Cyclicarx Business Overview

11.11.3 Cyclicarx AI-driven Drug Discovery Introduction

11.11.4 Cyclicarx Revenue in AI-driven Drug Discovery Business (2020-2025)

11.11.5 Cyclicarx Recent Development

11.12 Eli Lilly

11.12.1 Eli Lilly Company Details

11.12.2 Eli Lilly Business Overview

11.12.3 Eli Lilly AI-driven Drug Discovery Introduction

11.12.4 Eli Lilly Revenue in AI-driven Drug Discovery Business (2020-2025)

11.12.5 Eli Lilly Recent Development

11.13 Terray Therapeutics

11.13.1 Terray Therapeutics Company Details

11.13.2 Terray Therapeutics Business Overview

11.13.3 Terray Therapeutics AI-driven Drug Discovery Introduction

11.13.4 Terray Therapeutics Revenue in AI-driven Drug Discovery Business (2020-2025)

11.13.5 Terray Therapeutics Recent Development

11.14 Ardigen

11.14.1 Ardigen Company Details

11.14.2 Ardigen Business Overview

11.14.3 Ardigen AI-driven Drug Discovery Introduction

11.14.4 Ardigen Revenue in AI-driven Drug Discovery Business (2020-2025)

11.14.5 Ardigen Recent Development

11.15 ReviveMed

11.15.1 ReviveMed Company Details

11.15.2 ReviveMed Business Overview

11.15.3 ReviveMed AI-driven Drug Discovery Introduction

11.15.4 ReviveMed Revenue in AI-driven Drug Discovery Business (2020-2025)

11.15.5 ReviveMed Recent Development

11.16 Insilico Medicine

11.16.1 Insilico Medicine Company Details

11.16.2 Insilico Medicine Business Overview

11.16.3 Insilico Medicine AI-driven Drug Discovery Introduction

11.16.4 Insilico Medicine Revenue in AI-driven Drug Discovery Business (2020-2025)

11.16.5 Insilico Medicine Recent Development

11.17 XtalPi

11.17.1 XtalPi Company Details

11.17.2 XtalPi Business Overview

11.17.3 XtalPi AI-driven Drug Discovery Introduction

11.17.4 XtalPi Revenue in AI-driven Drug Discovery Business (2020-2025)

11.17.5 XtalPi Recent Development

11.18 MindRank

11.18.1 MindRank Company Details

11.18.2 MindRank Business Overview

11.18.3 MindRank AI-driven Drug Discovery Introduction

11.18.4 MindRank Revenue in AI-driven Drug Discovery Business (2020-2025)

11.18.5 MindRank Recent Development

11.19 DP Technology

11.19.1 DP Technology Company Details

11.19.2 DP Technology Business Overview

11.19.3 DP Technology AI-driven Drug Discovery Introduction

11.19.4 DP Technology Revenue in AI-driven Drug Discovery Business (2020-2025)

11.19.5 DP Technology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Selvita S.A

Exscientia Ltd

Euretos

Iktos

Eli Lilly

Ardigen

InSilico Medicine

XtalPi

DP Technology

Entos

Benevolent

Illumina with AstraZeneca

Novo Nordisk with Microsoft

Aqemia

Zephyr AI

Cyclicarx

Terray Therapeutics

ReviveMed

MindRank

List of Tables

Table 1. Global AI-driven Drug Discovery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Small Molecule Drug

Table 3. Key Players of Biological Modeling

Table 4. Key Players of Structural Biology

Table 5. Key Players of Others

Table 6. Global AI-driven Drug Discovery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global AI-driven Drug Discovery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global AI-driven Drug Discovery Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global AI-driven Drug Discovery Market Share by Region (2020-2025)

Table 10. Global AI-driven Drug Discovery Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global AI-driven Drug Discovery Market Share by Region (2026-2031)

Table 12. AI-driven Drug Discovery Market Trends

Table 13. AI-driven Drug Discovery Market Drivers

Table 14. AI-driven Drug Discovery Market Challenges

Table 15. AI-driven Drug Discovery Market Restraints

Table 16. Global AI-driven Drug Discovery Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global AI-driven Drug Discovery Market Share by Players (2020-2025)

Table 18. Global Top AI-driven Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-driven Drug Discovery as of 2024)

Table 19. Ranking of Global Top AI-driven Drug Discovery Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by AI-driven Drug Discovery Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of AI-driven Drug Discovery, Headquarters and Area Served

Table 22. Global Key Players of AI-driven Drug Discovery, Product and Application

Table 23. Global Key Players of AI-driven Drug Discovery, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global AI-driven Drug Discovery Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global AI-driven Drug Discovery Revenue Market Share by Type (2020-2025)

Table 27. Global AI-driven Drug Discovery Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global AI-driven Drug Discovery Revenue Market Share by Type (2026-2031)

Table 29. Global AI-driven Drug Discovery Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global AI-driven Drug Discovery Revenue Market Share by Application (2020-2025)

Table 31. Global AI-driven Drug Discovery Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global AI-driven Drug Discovery Revenue Market Share by Application (2026-2031)

Table 33. North America AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America AI-driven Drug Discovery Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America AI-driven Drug Discovery Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe AI-driven Drug Discovery Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe AI-driven Drug Discovery Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific AI-driven Drug Discovery Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific AI-driven Drug Discovery Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific AI-driven Drug Discovery Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America AI-driven Drug Discovery Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America AI-driven Drug Discovery Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa AI-driven Drug Discovery Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa AI-driven Drug Discovery Market Size by Country (2026-2031) & (US$ Million)

Table 48. Entos Company Details

Table 49. Entos Business Overview

Table 50. Entos AI-driven Drug Discovery Product

Table 51. Entos Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)

Table 52. Entos Recent Development

Table 53. Selvita Company Details

Table 54. Selvita Business Overview

Table 55. Selvita AI-driven Drug Discovery Product

Table 56. Selvita Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)

Table 57. Selvita Recent Development

Table 58. Benevolent Company Details

Table 59. Benevolent Business Overview

Table 60. Benevolent AI-driven Drug Discovery Product

Table 61. Benevolent Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)

Table 62. Benevolent Recent Development

Table 63. Exscientia Company Details

Table 64. Exscientia Business Overview

Table 65. Exscientia AI-driven Drug Discovery Product

Table 66. Exscientia Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)

Table 67. Exscientia Recent Development

Table 68. Euretos Company Details

Table 69. Euretos Business Overview

Table 70. Euretos AI-driven Drug Discovery Product

Table 71. Euretos Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)

Table 72. Euretos Recent Development

Table 73. Illumina with AstraZeneca Company Details

Table 74. Illumina with AstraZeneca Business Overview

Table 75. Illumina with AstraZeneca AI-driven Drug Discovery Product

Table 76. Illumina with AstraZeneca Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)

Table 77. Illumina with AstraZeneca Recent Development

Table 78. Novo Nordisk with Microsoft Company Details

Table 79. Novo Nordisk with Microsoft Business Overview

Table 80. Novo Nordisk with Microsoft AI-driven Drug Discovery Product

Table 81. Novo Nordisk with Microsoft Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)

Table 82. Novo Nordisk with Microsoft Recent Development

Table 83. Iktos Company Details

Table 84. Iktos Business Overview

Table 85. Iktos AI-driven Drug Discovery Product

Table 86. Iktos Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)

Table 87. Iktos Recent Development

Table 88. Aqemia Company Details

Table 89. Aqemia Business Overview

Table 90. Aqemia AI-driven Drug Discovery Product

Table 91. Aqemia Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)

Table 92. Aqemia Recent Development

Table 93. Zephyr AI Company Details

Table 94. Zephyr AI Business Overview

Table 95. Zephyr AI AI-driven Drug Discovery Product

Table 96. Zephyr AI Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)

Table 97. Zephyr AI Recent Development

Table 98. Cyclicarx Company Details

Table 99. Cyclicarx Business Overview

Table 100. Cyclicarx AI-driven Drug Discovery Product

Table 101. Cyclicarx Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)

Table 102. Cyclicarx Recent Development

Table 103. Eli Lilly Company Details

Table 104. Eli Lilly Business Overview

Table 105. Eli Lilly AI-driven Drug Discovery Product

Table 106. Eli Lilly Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)

Table 107. Eli Lilly Recent Development

Table 108. Terray Therapeutics Company Details

Table 109. Terray Therapeutics Business Overview

Table 110. Terray Therapeutics AI-driven Drug Discovery Product

Table 111. Terray Therapeutics Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)

Table 112. Terray Therapeutics Recent Development

Table 113. Ardigen Company Details

Table 114. Ardigen Business Overview

Table 115. Ardigen AI-driven Drug Discovery Product

Table 116. Ardigen Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)

Table 117. Ardigen Recent Development

Table 118. ReviveMed Company Details

Table 119. ReviveMed Business Overview

Table 120. ReviveMed AI-driven Drug Discovery Product

Table 121. ReviveMed Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)

Table 122. ReviveMed Recent Development

Table 123. Insilico Medicine Company Details

Table 124. Insilico Medicine Business Overview

Table 125. Insilico Medicine AI-driven Drug Discovery Product

Table 126. Insilico Medicine Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)

Table 127. Insilico Medicine Recent Development

Table 128. XtalPi Company Details

Table 129. XtalPi Business Overview

Table 130. XtalPi AI-driven Drug Discovery Product

Table 131. XtalPi Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)

Table 132. XtalPi Recent Development

Table 133. MindRank Company Details

Table 134. MindRank Business Overview

Table 135. MindRank AI-driven Drug Discovery Product

Table 136. MindRank Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)

Table 137. MindRank Recent Development

Table 138. DP Technology Company Details

Table 139. DP Technology Business Overview

Table 140. DP Technology AI-driven Drug Discovery Product

Table 141. DP Technology Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)

Table 142. DP Technology Recent Development

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. AI-driven Drug Discovery Picture

Figure 2. Global AI-driven Drug Discovery Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global AI-driven Drug Discovery Market Share by Type: 2024 VS 2031

Figure 4. Small Molecule Drug Features

Figure 5. Biological Modeling Features

Figure 6. Structural Biology Features

Figure 7. Others Features

Figure 8. Global AI-driven Drug Discovery Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global AI-driven Drug Discovery Market Share by Application: 2024 VS 2031

Figure 10. Pharmaceutical and Biotechnology Companies Case Studies

Figure 11. Research Laboratories Case Studies

Figure 12. AI-driven Drug Discovery Report Years Considered

Figure 13. Global AI-driven Drug Discovery Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global AI-driven Drug Discovery Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global AI-driven Drug Discovery Market Share by Region: 2024 VS 2031

Figure 16. Global AI-driven Drug Discovery Market Share by Players in 2024

Figure 17. Global Top AI-driven Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-driven Drug Discovery as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by AI-driven Drug Discovery Revenue in 2024

Figure 19. North America AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America AI-driven Drug Discovery Market Share by Country (2020-2031)

Figure 21. United States AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe AI-driven Drug Discovery Market Share by Country (2020-2031)

Figure 25. Germany AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific AI-driven Drug Discovery Market Share by Region (2020-2031)

Figure 33. China AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America AI-driven Drug Discovery Market Share by Country (2020-2031)

Figure 41. Mexico AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa AI-driven Drug Discovery Market Share by Country (2020-2031)

Figure 45. Turkey AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Entos Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)

Figure 49. Selvita Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)

Figure 50. Benevolent Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)

Figure 51. Exscientia Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)

Figure 52. Euretos Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)

Figure 53. Illumina with AstraZeneca Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)

Figure 54. Novo Nordisk with Microsoft Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)

Figure 55. Iktos Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)

Figure 56. Aqemia Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)

Figure 57. Zephyr AI Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)

Figure 58. Cyclicarx Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)

Figure 59. Eli Lilly Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)

Figure 60. Terray Therapeutics Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)

Figure 61. Ardigen Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)

Figure 62. ReviveMed Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)

Figure 63. Insilico Medicine Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)

Figure 64. XtalPi Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)

Figure 65. MindRank Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)

Figure 66. DP Technology Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Artificial Intelligence AI in Drug Discovery Market Insights Forecast to 2030

Global Artificial Intelligence Drug R D Market Research Report 2024

AI Drug Discovery Platform Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global AI for Drug Discovery and Development Market Research Report 2025

Global AI Technology in Pharmaceutical Market Research Report 2024

AI assisted Drug Design AIDD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global AI Drug Discovery Software Market Research Report 2024

Global Drug Developing Platforms by Artificial Intelligence AI Market Research Report 2024

AI Drug Development Platform Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Machine Learning in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global AI for Pharma and Biotech Market Insights Forecast to 2030

Global Drug Discovery AI Tools Market Research Report 2025

Artificial Intelligence For Drug Development and Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Artificial Intelligence Discovers Molecules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global AI Assisted Drug Discovery Software Market Research Report 2024

Global AI based Clinical Trials Solution Provider Market Research Report 2024

AI Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Artificial Intelligence AI in Biotechnology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Artificial Intelligence in Drug Discovery and Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions